Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

N De Stefano1, P M Matthews, M Filippi

  • 1Institute of Neurological Sciences, University of Siena, Italy. destefano@unisi.it

Neurology
|April 12, 2003
PubMed
Abstract

Insights

Multiple sclerosis (MS) patients show significant gray matter volume loss, even early in the disease. This cortical gray matter reduction contributes to disability in both relapsing-remitting (RR) and primary progressive (PP) MS.

Area of Science:

  • Neurology
  • Neuroimaging
  • Neurodegeneration

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Gray matter (GM) pathology, including cortical GM, is increasingly recognized in MS.
  • Understanding GM changes is crucial for assessing disease progression and disability.

Purpose of the Study:

  • To quantify cortical GM volume changes in patients with relapsing-remitting (RR) and primary progressive (PP) MS.
  • To determine the association between cortical GM volume and clinical disability.
  • To investigate the relationship between cortical GM changes and white matter (WM) inflammatory lesions.

Main Methods:

  • Conventional MRI scans were acquired from definite MS patients (RR and PP forms).
  • Automated analysis of T1-weighted MR images was used to calculate normalized cortical volumes (NCV).
  • Proton density and T2-weighted images assessed total brain lesion load; correlations with disability scores were analyzed.

Main Results:

  • Both RR and PP MS patients exhibited significantly lower NCV compared to controls.
  • NCV reduction was evident even in early disease stages (<5 years) and with minimal lesion load.
  • NCV correlated negatively with T2 lesion load and disease duration in RR MS, and strongly with disability scores in PP MS.

Conclusions:

  • Substantial neocortical volume loss occurs in MS, indicating early GM pathology in both RR and PP forms.
  • Cortical GM changes contribute significantly to neurologic impairment.
  • While partly secondary to WM inflammation, an independent neurodegenerative process is suggested, particularly in PP MS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...